Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)

NCT04501380 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Small Intestinal Bacterial Overgrowth
Gastrointestinal Disease
Gastrointestinal Infection

Interventions

DRUG: AEMCOLO (Rifamycin SV MMX)

Sponsor

Bradley Connor